R M Blaese

Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential.

L. Liotta, W. Stetler-Stevenson, R. Blaese, 1992, Cancer research.

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.

W F Anderson, Z. Ram, W. Anderson, 1993, Human gene therapy.

A multiinstitutional survey of the Wiskott-Aldrich syndrome.

K. Sullivan, R. Blaese, J. Winkelstein, 1994, The Journal of pediatrics.

Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro.

S. Broder, I. Magrath, H. Kirchner, 1979, Journal of immunology.

Improved methods of retroviral vector transduction and production for gene therapy.

W F Anderson, G J McGarrity, W. Anderson, 1994, Human gene therapy.

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.

R. Blaese, C. Mullen, M. Kilstrup, 1992, Proceedings of the National Academy of Sciences of the United States of America.

B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.

I. Magrath, R. Blaese, G. Tosato, 1980, The Journal of clinical investigation.

T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.

I. Magrath, R. Blaese, G. Tosato, 1982, Journal of immunology.